These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12545287)

  • 21. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy for age-related macular degeneration.
    Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
    Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization.
    Frennesson CI
    Acta Ophthalmol Scand; 2004 Dec; 82(6):651-5. PubMed ID: 15606459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
    Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
    Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Submacular hemorrhage following photodynamic therapy in the treatment of choroidal neovascularization].
    Díaz-de-Durana-Santa-Coloma E; Fernández-Ares ML; Iturralde-Errea D; Salazar-Díez JL; Vázquez-Cruchaga E; López-Garrido JA
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):685-91. PubMed ID: 17199162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Massive hemorrhage following photodynamic therapy in exudative ARMD].
    Hartmann L; Adenis JP; Robert PY
    J Fr Ophtalmol; 2008 Sep; 31(7):714.e1-7. PubMed ID: 18971847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Photodynamic therapy with verteporfin in occult choroidal neovascularization in age-related macular degeneration].
    Kürzinger GR; Stender B; Lang GK; Lang GE
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):501-6. PubMed ID: 20349399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural course of occult choroidal neovascularization in age-related macular degeneration: development of classic lesions in fluorescein angiography.
    Schneider U; Gelisken F; Inhoffen W
    Acta Ophthalmol Scand; 2005 Apr; 83(2):141-7. PubMed ID: 15799723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
    Slakter JS; Bochow TW; D'Amico DJ; Marks B; Jerdan J; Sullivan EK; Robertson SM; Slakter JS; Sullins G; Zilliox P;
    Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonarteritic anterior ischemic optic neuropathy after photodynamic therapy for choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):424-6. PubMed ID: 15295679
    [No Abstract]   [Full Text] [Related]  

  • 34. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 35. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A; Isola V; Vadalà M; Calori G
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Axer-Siegel R; Ehrlich R; Rosenblatt I; Kramer M; Priel E; Yassur Y; Weinberger D
    Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
    Gelisken F; Inhoffen W; Partsch M; Schneider U; Kreissig I
    Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.
    Sharma S; Bakal J; Oliver-Fernandez A; Blair J
    Arch Ophthalmol; 2004 Jun; 122(6):853-6. PubMed ID: 15197060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.